J N Ingle

Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials.

S. Martino, J. Ingle, C. Osborne, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer.

E. Perez, M. Dowsett, J. Ingle, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.

E. Perez, J. Ingle, J. Krook, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.

T. Whelan, J. Ingle, P. Goss, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer

J. Forbes, J. Ingle, K. Pritchard, 1997, Breast Cancer Research and Treatment.

Current status of adjuvant endocrine therapy for breast cancer.

J. Ingle, J N Ingle, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.